|
Report Date : |
30.04.2012 |
IDENTIFICATION DETAILS
|
Name : |
EGY PHARMA CO SAE |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Year of Establishment : |
2009 |
|
|
|
|
Com. Reg. No.: |
36728, Cairo |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Distributors of pharmaceutical products |
|
|
|
|
No. of Employees : |
185 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
Regular |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Egypt |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : EGY PHARMA CO SAE
Country of Origin : Egypt
Legal Form : Egyptian Joint Stock Company
Registration Date : 2009
Commercial Registration Number : 36728, Cairo
Tax Card Number : 310-315-804
Issued Capital : £E 5,916,400
Paid up Capital : £E 5,916,400
Total Workforce : 185
Activities : Distributors of pharmaceutical products
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
EGY PHARMA CO SAE
Registered &
Physical Address
Street : 24 Abbass El Akkad Street
Area : Nasr City
PO Box : 11371
Town : Cairo
Country : Egypt
Telephone : (20-2) 22713873 / 2228991
Facsimile : (20-2) 22871991
Premises
Subject operates
from a large suite of offices and a warehouse that are rented and located in
the Central Business Area of Cairo.
Branch Office
(s)
Location Description
·
38
Gamal El Din Kassem Street Office
premises
8th District
Nasr City
Cairo
·
26 Nour
El Din Bahgat Street Office
premises
El Serag Mall
8th District
Nasr City
Cairo
Name Position
·
Yasser
Hefny Mohamed Mahmoud Chairman
·
Hassan
Ali Abd El Wahab General
Manager
·
Ahmed
Mohamed El Taher Tayel Financial
Manager
·
Saber
Hussein Ayoub Hussein Technical
Manager
Date of Establishment : 2009
Legal Form :
Egyptian Joint Stock
Company
Commercial Reg. No. : 36728, Cairo
Tax
Card No. : 310-315-804
Issued Capital : £E 5,916,400
Paid up Capital : £E 5,916,400
Name of Shareholder
(s) Percentage
·
Yasser
Hefny Mohamed Mahmoud 96.83%
·
Dina
Tag El Din Hassan Ibrahim 3.00%
·
Mohamed
Abd El Azim Ghazaly Ibrahim 0.17%
Activities: Engaged in the import and distribution of
pharmaceutical products.
Import
Countries: Taiwan, India,
China, Switzerland, Netherlands, Germany, Canada and the United Kingdom.
Operating Trend: Steady
Subject has a
workforce of 185 employees.
Financial
highlights provided by local sources are given below:
Currency: Egyptian
Pounds (£E)
Year
Ending 31/12/10: Year
Ending 31/12/11:
Total Sales £E 17,462,236 £E 19,381,843
Local sources
consider subject’s financial condition to be Fair.
The above financial
figures are based on estimations by our local sources.
·
National
Bank of Egypt
Cairo
Tel: (20-2) 33924175
Fax: (20-2) 33924143
No complaints
regarding subject’s payments have been reported.
Local sources report
that payment obligations are met in a generally timely manner and the operating
history is clear. As such the company is deemed a fair trade risk and the above
credit figure is considered to be within subject’s financial means.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.52.68 |
|
UK Pound |
1 |
Rs.85.12 |
|
Euro |
1 |
Rs.69.38 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.